Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGND) Shareholders' Equity

2.8 / 5 stars · 68/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Shareholders' Equity

LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Shareholders' Equity of $967.52 million as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:StockholdersEquity · last filed 2026-08-07

  • 2026-06-30: Stockholders' Equity Attributable to Parent $967.52M.
  • 2026-03-31: Stockholders' Equity Attributable to Parent $997.32M.
  • 2025-12-31: Stockholders' Equity Attributable to Parent $1.02B.
  • 2025-09-30: Stockholders' Equity Attributable to Parent $950.17M.
Period endStockholders' Equity Attributable to ParentStockholders' Equity Attributable to Parent as first filed
2026-06-30$967.52M
10-Q · filed 2026-08-07
2026-03-31$997.32M
10-Q · filed 2026-08-07
2025-12-31$1.02B
10-Q · filed 2026-08-07
2025-09-30$950.17M
10-Q · filed 2025-11-07
2025-06-30$827.31M
10-Q · filed 2026-08-07
$828.53M
10-Q · filed 2025-08-08
2025-03-31$795.59M
10-Q · filed 2026-08-07
$795.53M
10-Q · filed 2025-05-09
2024-12-31$830.44M
10-Q · filed 2026-08-07
2024-09-30$841.18M
10-Q · filed 2025-11-07
2024-06-30$775.20M
10-Q · filed 2025-11-07
2024-03-31$806.52M
10-Q · filed 2025-11-07
2023-12-31$700.91M
10-K · filed 2026-02-27
2023-09-30$667.90M
10-Q · filed 2024-11-08
2023-06-30$664.89M
10-Q · filed 2024-11-08
2023-03-31$646.32M
10-Q · filed 2024-11-08
2022-12-31$597.49M
10-K · filed 2026-02-27
2022-09-30$816.30M
10-Q · filed 2023-11-09
2022-06-30$802.37M
10-Q · filed 2023-11-09
2022-03-31$793.19M
10-Q · filed 2023-11-09
2021-12-31$821.16M
10-K · filed 2025-02-28
2021-09-30$812.07M
10-Q · filed 2022-11-08
2021-06-30$786.52M
10-Q · filed 2022-11-08
2021-03-31$745.84M
10-Q · filed 2022-11-08
2020-12-31$709.52M
10-K · filed 2024-02-29
2020-09-30$697.82M
10-Q · filed 2021-11-09
2020-06-30$695.00M
10-Q · filed 2021-11-09
2020-03-31$661.90M
10-Q · filed 2021-11-09
2019-12-31$767.23M
10-K · filed 2023-02-28
2019-09-30$850.58M
10-Q · filed 2020-11-06
2019-06-30$1.04B
10-Q · filed 2020-11-06
2019-03-31$1.08B
10-Q · filed 2020-11-06
2018-12-31$560.91M
10-K · filed 2022-02-28
2018-09-30$699.52M
10-Q · filed 2019-11-08
2018-06-30$619.81M
10-Q · filed 2019-11-08
2018-03-31$481.10M
10-Q · filed 2019-11-08
2017-12-31$399.79M
10-Q · filed 2019-11-08
2017-09-30$403.17M
10-Q · filed 2017-11-09
2017-06-30$385.12M
10-Q · filed 2017-08-09
2017-03-31$371.83M
10-Q · filed 2017-05-09
2016-12-31$341.29M
10-K · filed 2018-03-01
2016-09-30$338.25M
10-Q · filed 2016-11-14
2016-06-30$329.76M
10-Q · filed 2016-11-14
$391.92M
10-Q · filed 2016-08-04
2016-03-31$364.60M
10-Q · filed 2016-11-14
$392.08M
10-Q · filed 2016-05-09
2015-12-31$237.28M
10-K · filed 2017-02-28
$304.39M
10-K · filed 2016-02-26
2015-09-30$266.81M
10-Q · filed 2016-11-14
$292.18M
10-Q · filed 2015-11-09
2015-06-30$69.05M
10-Q · filed 2015-08-05
2015-03-31$35.15M
10-Q · filed 2015-05-11
2014-12-31$26.32M
10-K · filed 2016-11-14
$49.61M
10-K · filed 2014-12-01
2014-09-30$44.37M
10-Q · filed 2014-10-31
2014-06-30$64.17M
10-Q · filed 2014-08-05
2014-03-31$65.00M
10-Q · filed 2014-05-07
2013-12-31$49.61M
10-K · filed 2015-02-23
2013-09-30$44.81M
10-Q · filed 2013-11-08
2013-06-30$39.27M
10-Q · filed 2013-08-01
2013-03-31$30.60M
10-Q · filed 2013-05-08
2012-12-31$26.48M
10-K/A · filed 2014-12-12
2012-09-30$21.23M
10-Q · filed 2012-11-14
2012-06-30$17.48M
10-Q/A · filed 2012-11-14
$18.45M
10-Q · filed 2012-08-08
2011-12-31$8.19M
10-K · filed 2013-03-14
$8.65M
10-K · filed 2012-02-23
2011-09-30$3.06M
10-Q/A · filed 2012-02-10
$2.37M
10-Q · filed 2011-11-08
2011-06-30$5.87M
10-Q/A · filed 2012-02-10
$5.33M
10-Q · filed 2011-08-08
2010-12-31-$4.85M
10-K/A · filed 2012-11-14
-$4.85M
10-Q · filed 2011-08-08
2009-12-31$3.74M
10-K/A · filed 2012-11-14
2008-12-31-$10.37M
10-K/A · filed 2012-11-14